Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Tuberculosis | Research

Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung

Authors: Hongyun Ruan, Fangchao Liu, Ming Han, Changfan Gong

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

The purpose of this study was to determine risk factors of postoperative complications in tuberculosis-destroyed lung (TDL) patients.

Methods

We retrospectively analyzed the data from all consecutive TDL patients undergoing surgical treatment at the Beijing Chest Hospital from January 2001 to September 2019.

Results

Of 113 TDL cases experiencing surgery, 33 (29.2%) experienced postoperative complications. The patients with low BMI were more likely to have postoperative complications compared to those with normal BMI, whereas a significant lower rate of postoperative complications was noted in patients with BMI ≥ 25 kg/m2. In addition, significant increased risk was observed in patients with smoking history. We found that the patients with underlying infection, including aspergillus and nontuberculous mycobacteria (NTM), had significantly higher odds of having postoperative complications compared with those without underlying infection. The anaemia was another important independent factor associated with postoperative complication. Patients with blood transfusion above 1000 mL had a strongly increased frequency of postoperative complications than patients with blood transfusion below 1000 mL.

Conclusion

In conclusion, our data demonstrate that approximate one third of TDL patients experience postoperative complications in our cohort. Patients with low BMI, anaemia, tobacco smoking, and coinfected aspergillus or NTM are at markedly higher risk to experience postoperative complications after pneumonectomy.
Literature
1.
go back to reference Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8(1):19.CrossRef Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8(1):19.CrossRef
2.
go back to reference Raviglione M, Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infect Dis Rep. 2016;8(2):6570.CrossRef Raviglione M, Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infect Dis Rep. 2016;8(2):6570.CrossRef
3.
go back to reference Xu C, Pang Y, Li R, et al. Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China. J Infect. 2018;76(4):348–53.CrossRef Xu C, Pang Y, Li R, et al. Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China. J Infect. 2018;76(4):348–53.CrossRef
4.
go back to reference Owolabi OA, Jallow AO, Jallow M, et al. Delay in the diagnosis of pulmonary tuberculosis in The Gambia, West Africa: a cross-sectional study. Int J Infect Dis. 2020;101:102–6.CrossRef Owolabi OA, Jallow AO, Jallow M, et al. Delay in the diagnosis of pulmonary tuberculosis in The Gambia, West Africa: a cross-sectional study. Int J Infect Dis. 2020;101:102–6.CrossRef
5.
go back to reference Kim CJ, Yoon HK, Park MJ, et al. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. Int J Chron Obstruct Pulmon Dis. 2017;12:1589–96.CrossRef Kim CJ, Yoon HK, Park MJ, et al. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. Int J Chron Obstruct Pulmon Dis. 2017;12:1589–96.CrossRef
6.
go back to reference Han D, Lee HY, Kim K, Kim T, Oh YM, Rhee CK. Burden and clinical characteristics of high grade tuberculosis destroyed lung: a nationwide study. J Thorac Dis. 2019;11(10):4224–33.CrossRef Han D, Lee HY, Kim K, Kim T, Oh YM, Rhee CK. Burden and clinical characteristics of high grade tuberculosis destroyed lung: a nationwide study. J Thorac Dis. 2019;11(10):4224–33.CrossRef
7.
go back to reference Li Y, Hu X, Jiang G, Chen C. Pneumonectomy for treatment of destroyed lung: a retrospective study of 137 patients. Thorac Cardiovasc Surg. 2017;65(7):528–34.CrossRef Li Y, Hu X, Jiang G, Chen C. Pneumonectomy for treatment of destroyed lung: a retrospective study of 137 patients. Thorac Cardiovasc Surg. 2017;65(7):528–34.CrossRef
8.
go back to reference Bai L, Hong Z, Gong C, Yan D, Liang Z. Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs. Eur J Cardiothorac Surg. 2012;41(2):335–40.CrossRef Bai L, Hong Z, Gong C, Yan D, Liang Z. Surgical treatment efficacy in 172 cases of tuberculosis-destroyed lungs. Eur J Cardiothorac Surg. 2012;41(2):335–40.CrossRef
9.
go back to reference Rhee CK, Yoo KH, Lee JH, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis. 2013;17(1):67–75.CrossRef Rhee CK, Yoo KH, Lee JH, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis. 2013;17(1):67–75.CrossRef
10.
go back to reference WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.CrossRef WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.CrossRef
11.
go back to reference Jee SH, Golub JE, Jo J, Park IS, Ohrr H, Samet JM. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol. 2009;170(12):1478–85.CrossRef Jee SH, Golub JE, Jo J, Park IS, Ohrr H, Samet JM. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol. 2009;170(12):1478–85.CrossRef
12.
go back to reference Brusasco V, Crapo R, Viegi G. American Thoracic Society, European Respiratory Society. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005;26(1):1–2.CrossRef Brusasco V, Crapo R, Viegi G. American Thoracic Society, European Respiratory Society. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005;26(1):1–2.CrossRef
13.
go back to reference Ruan H, Gong C, Wang J. The efficacy and safety of surgical treatment for patients with tuberculosis destroyed lung with or without chronic pulmonary aspergillosis. World J Surg. 2021;45(5):1595–601.CrossRef Ruan H, Gong C, Wang J. The efficacy and safety of surgical treatment for patients with tuberculosis destroyed lung with or without chronic pulmonary aspergillosis. World J Surg. 2021;45(5):1595–601.CrossRef
14.
go back to reference Halezeroglu S, Keles M, Uysal A, et al. Factors affecting postoperative morbidity and mortality in destroyed lung. Ann Thorac Surg. 1997;64(6):1635–8.CrossRef Halezeroglu S, Keles M, Uysal A, et al. Factors affecting postoperative morbidity and mortality in destroyed lung. Ann Thorac Surg. 1997;64(6):1635–8.CrossRef
15.
go back to reference van Venrooij LM, de Vos R, Borgmeijer-Hoelen MM, Haaring C, de Mol BA. Preoperative unintended weight loss and low body mass index in relation to complications and length of stay after cardiac surgery. Am J Clin Nutr. 2008;87(6):1656–61.CrossRef van Venrooij LM, de Vos R, Borgmeijer-Hoelen MM, Haaring C, de Mol BA. Preoperative unintended weight loss and low body mass index in relation to complications and length of stay after cardiac surgery. Am J Clin Nutr. 2008;87(6):1656–61.CrossRef
16.
go back to reference Engelman DT, Adams DH, Byrne JG, et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg. 1999;118(5):866–73.CrossRef Engelman DT, Adams DH, Byrne JG, et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg. 1999;118(5):866–73.CrossRef
17.
go back to reference Solomons NW. Malnutrition and infection: an update. Br J Nutr. 2007;98(Suppl 1):S5-10.CrossRef Solomons NW. Malnutrition and infection: an update. Br J Nutr. 2007;98(Suppl 1):S5-10.CrossRef
18.
go back to reference Pakasi TA, Karyadi E, Wibowo Y, et al. Vitamin A deficiency and other factors associated with severe tuberculosis in Timor and Rote Islands, East Nusa Tenggara Province. Indonesia Eur J Clin Nutr. 2009;63(9):1130–5.CrossRef Pakasi TA, Karyadi E, Wibowo Y, et al. Vitamin A deficiency and other factors associated with severe tuberculosis in Timor and Rote Islands, East Nusa Tenggara Province. Indonesia Eur J Clin Nutr. 2009;63(9):1130–5.CrossRef
19.
go back to reference Matveychuk A, Fuks L, Priess R, Hahim I, Shitrit D. Clinical and radiological features of Mycobacterium kansasii and other NTM infections. Respir Med. 2012;106(10):1472–7.CrossRef Matveychuk A, Fuks L, Priess R, Hahim I, Shitrit D. Clinical and radiological features of Mycobacterium kansasii and other NTM infections. Respir Med. 2012;106(10):1472–7.CrossRef
Metadata
Title
Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung
Authors
Hongyun Ruan
Fangchao Liu
Ming Han
Changfan Gong
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01641-0

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.